Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3 - WILLIS TOWERS WATSON PLC - Amendment

4th May 2021 07:00

 

FORM 8.3 Amendment to sales and purchase

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)

Barclays PLC.

Company dealt in

WILLIS TOWERS WATSON PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

ORD

Date of dealing

28 April 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:ORD
LongShort
Number(%)Number(%)

(1)

Relevant securities

1,736,824

1.35%

175,858

0.14%

 

(2)

Derivatives (other than options):

72,359

0.06%

7,134

0.01%

 

(3)

Options and agreements to
purchase/sell:

6,100

0.00%

6,100

0.00%

 
TOTAL:

1,815,283

1.41%

189,092

0.15%

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/saleNumber of relevant securitiesPrice per unit
Purchase

1

236.2300 USD
Purchase

1

245.6050 USD
Purchase

3

245.2900 USD
Purchase

21

245.1800 USD
Purchase

83

240.0000 USD
Purchase

100

244.9700 USD
Purchase

100

240.6950 USD
Purchase

100

240.1450 USD
Purchase

200

235.2800 USD
Purchase

200

240.2625 USD
Purchase

200

240.0675 USD
Purchase

202

239.7366 USD
Purchase

236

245.8806 USD
Purchase

300

239.7683 USD
Purchase

300

243.8133 USD
Purchase

400

239.7600 USD
Purchase

484

245.0859 USD
Purchase

574

245.2189 USD
Purchase

1,417

239.8616 USD
Purchase

4,623

241.5393 USD
Purchase

8,227

245.0420 USD
Purchase

10,359

242.7451 USD
Purchase

12,514

245.8624 USD
Purchase

17,802

242.7293 USD
Purchase

17,890

242.8421 USD
Purchase

23,760

245.8800 USD
Purchase

69,892

243.4269 USD
Purchase

70,000

244.1800 USD
Sale

1

243.7050 USD
Sale

2

244.4175 USD
Sale

2

243.5700 USD
Sale

3

245.0700 USD
Sale

3

245.3500 USD
Sale

3

244.1566 USD
Sale

4

243.7000 USD
Sale

5

243.4990 USD
Sale

6

244.3583 USD
Sale

6

244.5775 USD
Sale

6

245.0208 USD
Sale

6

243.7841 USD
Sale

7

244.2614 USD
Sale

7

246.3900 USD
Sale

8

246.0012 USD
Sale

14

246.0800 USD
Sale

14

246.2350 USD
Sale

17

244.7902 USD
Sale

21

243.0650 USD
Sale

21

245.1800 USD
Sale

35

244.2260 USD
Sale

35

245.8780 USD
Sale

51

241.1780 USD
Sale

71

242.9790 USD
Sale

78

245.9208 USD
Sale

100

244.7700 USD
Sale

100

245.8400 USD
Sale

178

246.1366 USD
Sale

200

235.2800 USD
Sale

238

245.8389 USD
Sale

256

244.8317 USD
Sale

291

238.8120 USD
Sale

400

242.2800 USD
Sale

700

245.9814 USD
Sale

800

245.3462 USD
Sale

885

245.7187 USD
Sale

1,021

244.9090 USD
Sale

1,026

244.4072 USD
Sale

2,177

242.5325 USD
Sale

2,297

243.1195 USD
Sale

2,626

245.1652 USD
Sale

3,002

239.9118 USD
Sale

3,120

241.6332 USD
Sale

4,438

244.7964 USD
Sale

4,447

243.3873 USD
Sale

12,519

245.8769 USD
Sale

12,947

242.7116 USD
Sale

13,741

243.7290 USD
Sale

15,693

242.7843 USD
Sale

17,839

242.8398 USD
Sale

22,544

245.8800 USD
Sale

44,762

243.2560 USD
Sale

70,000

244.1800 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 attached? (Note 9) YES

Date of disclosure

30 April 2021

Contact name

Large Holdings Regulatory Operations

Telephone number

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product nameWritten orNumber ofExerciseTypeExpiry
purchasedrelevant securitiespricedate
to which the option
or derivative
relates
Put OptionsPurchased

-100

220.0000

AmericanJul 16, 2021
Call OptionsPurchased

100

240.0000

AmericanJul 16, 2021
Call OptionsPurchased

6,000

220.0000

AmericanJul 16, 2021
Put OptionsPurchased

-6,000

200.0000

AmericanJul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210503005073/en/

Copyright Business Wire 2021


Related Shares:

Barclays
FTSE 100 Latest
Value8,837.91
Change26.87